Cargando…

In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR

A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a com...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawar, Gopal, Madden, Judith C., Ebbrell, David, Firman, James W., Cronin, Mark T. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580867/
https://www.ncbi.nlm.nih.gov/pubmed/31244651
http://dx.doi.org/10.3389/fphar.2019.00561
_version_ 1783428101718409216
author Pawar, Gopal
Madden, Judith C.
Ebbrell, David
Firman, James W.
Cronin, Mark T. D.
author_facet Pawar, Gopal
Madden, Judith C.
Ebbrell, David
Firman, James W.
Cronin, Mark T. D.
author_sort Pawar, Gopal
collection PubMed
description A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data.
format Online
Article
Text
id pubmed-6580867
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65808672019-06-26 In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR Pawar, Gopal Madden, Judith C. Ebbrell, David Firman, James W. Cronin, Mark T. D. Front Pharmacol Pharmacology A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data. Frontiers Media S.A. 2019-06-11 /pmc/articles/PMC6580867/ /pubmed/31244651 http://dx.doi.org/10.3389/fphar.2019.00561 Text en Copyright © 2019 Pawar, Madden, Ebbrell, Firman and Cronin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pawar, Gopal
Madden, Judith C.
Ebbrell, David
Firman, James W.
Cronin, Mark T. D.
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_full In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_fullStr In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_full_unstemmed In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_short In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_sort in silico toxicology data resources to support read-across and (q)sar
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580867/
https://www.ncbi.nlm.nih.gov/pubmed/31244651
http://dx.doi.org/10.3389/fphar.2019.00561
work_keys_str_mv AT pawargopal insilicotoxicologydataresourcestosupportreadacrossandqsar
AT maddenjudithc insilicotoxicologydataresourcestosupportreadacrossandqsar
AT ebbrelldavid insilicotoxicologydataresourcestosupportreadacrossandqsar
AT firmanjamesw insilicotoxicologydataresourcestosupportreadacrossandqsar
AT croninmarktd insilicotoxicologydataresourcestosupportreadacrossandqsar